These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22690078)

  • 1. Colorectal cancer screening: comparison of transferrin and immuno fecal occult blood test.
    Chen JG; Cai J; Wu HL; Xu H; Zhang YX; Chen C; Wang Q; Xu J; Yuan XL
    World J Gastroenterol; 2012 Jun; 18(21):2682-8. PubMed ID: 22690078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing Fecal Occult Blood Test (FOBT) Colorectal Cancer Screening Using Gut Bacteriome as a Biomarker.
    Chowdhury MR; Hone KGMS; Prévost K; Balthazar P; Avino M; Arguin M; Beaudoin J; Malick M; Desgagné M; Robert G; Scott M; Dubé J; Laforest-Lapointe I; Massé E
    Clin Colorectal Cancer; 2024 Mar; 23(1):22-34.e2. PubMed ID: 37980216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive values of an immunological fecal occult blood test for the diagnosis of colorectal cancer compared using colonoscopy in symptomatic patients in Yaounde (Cameroon).
    Jovanka TU; Wilson NNA; Winnie BN; Paule NM; Paul T; Isabelle DB; Magloire BS
    BMC Gastroenterol; 2024 Jun; 24(1):198. PubMed ID: 38877426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection.
    Haug U; Knudsen AB; Lansdorp-Vogelaar I; Kuntz KM
    Int J Cancer; 2015 Jun; 136(12):2864-74. PubMed ID: 25403937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for colorectal cancer by full colonoscopy in first-degree relatives of colorectal cancer patients: a multicentric study by the Italian League for the Fight against Cancer.
    Diedenhofen G; Morgia A; Sinnona N; Pacchiarotti A; Fiaschetti A; Forte V; Tosoni M; Liberati F; Boschetto S; Zepponi E; Marogna P; Manca A; Bisail M; Vestri A; Rossi A
    Ann Ig; 2024; 36(5):537-548. PubMed ID: 38465396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening.
    Imperiale TF; Porter K; Zella J; Gagrat ZD; Olson MC; Statz S; Garces J; Lavin PT; Aguilar H; Brinberg D; Berkelhammer C; Kisiel JB; Limburg PJ;
    N Engl J Med; 2024 Mar; 390(11):984-993. PubMed ID: 38477986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projected Colorectal Cancer Incidence and Mortality Based on Observed Adherence to Colonoscopy and Sequential Stool-Based Screening.
    Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Church TR; Allen JI; Feld AD; Mills G; Jordan PA; Corley DA; Doubeni CA; Hahn AI; Lobaugh SM; Fleisher M; O'Brien MJ; Zauber AG
    Am J Gastroenterol; 2024 Jul; 119(7):1392-1401. PubMed ID: 38318949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.
    Chung DC; Gray DM; Singh H; Issaka RB; Raymond VM; Eagle C; Hu S; Chudova DI; Talasaz A; Greenson JK; Sinicrope FA; Gupta S; Grady WM
    N Engl J Med; 2024 Mar; 390(11):973-983. PubMed ID: 38477985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme.
    Khuhaprema T; Sangrajrang S; Lalitwongsa S; Chokvanitphong V; Raunroadroong T; Ratanachu-Ek T; Muwonge R; Lucas E; Wild C; Sankaranarayanan R
    BMJ Open; 2014 Jan; 4(1):e003671. PubMed ID: 24435889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to Colonoscopy After Abnormal Stool-Based Screening and Risk for Colorectal Cancer Incidence and Mortality.
    San Miguel Y; Demb J; Martinez ME; Gupta S; May FP
    Gastroenterology; 2021 May; 160(6):1997-2005.e3. PubMed ID: 33545140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of Septin9, SRSF1, and PAX8 in Early Screening of Colorectal Cancer in the Population Undergoing Physical Examinations.
    Li Q; Jiang W; Zhang Y; Yang X; Huang T; Huang Y; Yang S; Wang Q
    Clin Lab; 2023 Dec; 69(12):. PubMed ID: 38084698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate and associated factors of refusal to perform immunochemical Faecal Occult Blood Test (iFOBT) among semi-urban communities.
    Syed Soffian SS; Safian N; Nawi AM; Ahmad SB; Chan HK; Abu Hassan MR
    PLoS One; 2021; 16(10):e0258129. PubMed ID: 34618854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis.
    Haug U; Knudsen AB; Kuntz KM
    Int J Cancer; 2012 Nov; 131(9):2094-102. PubMed ID: 22307927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers.
    Niv Y; Lev-El M; Fraser G; Abuksis G; Tamir A
    Gut; 2002 Jan; 50(1):33-7. PubMed ID: 11772964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer and adenoma screening using urinary volatile organic compound (VOC) detection: early results from a single-centre bowel screening population (UK BCSP).
    Mozdiak E; Wicaksono AN; Covington JA; Arasaradnam RP
    Tech Coloproctol; 2019 Apr; 23(4):343-351. PubMed ID: 30989415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations.
    Nadel MR; Berkowitz Z; Klabunde CN; Smith RA; Coughlin SS; White MC
    J Gen Intern Med; 2010 Aug; 25(8):833-9. PubMed ID: 20383599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal Cancer Screening for Persons With a Positive Family History—Evaluation of the FARKOR Program for the Secondary Prevention of Colorectal Cancer in Persons Aged 25 to 50.
    Crispin A; Rehms R; Hoffmann S; Lindoerfer D; Hallsson LR; Jahn B; Mühlberger N; Sroczynski G; Siebert U; Mansmann U
    Dtsch Arztebl Int; 2023 Nov; 120(46):786-792. PubMed ID: 37855423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a predictive model for detection of colorectal cancer in primary care by analysis of complete blood counts: a binational retrospective study.
    Kinar Y; Kalkstein N; Akiva P; Levin B; Half EE; Goldshtein I; Chodick G; Shalev V
    J Am Med Inform Assoc; 2016 Sep; 23(5):879-90. PubMed ID: 26911814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Trial of Facilitated Adherence to Screening Colonoscopy vs Sequential Fecal-Based Blood Test.
    Zauber AG; Winawer SJ; O'Brien MJ; Mills GM; Allen JI; Feld AD; Jordan PA; Fleisher M; Orlow I; Meester RGS; Lansdorp-Vogelaar I; Rutter CM; Knudsen AB; Mandelson M; Shaukat A; Mendelsohn RB; Hahn AI; Lobaugh SM; Soto Palmer B; Serrano V; Kumar JR; Fischer SE; Chen JC; Bayuga-Miller S; Kuk D; O'Connell K; Church TR
    Gastroenterology; 2023 Jul; 165(1):252-266. PubMed ID: 36948424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the impact of public health initiatives on trends in fecal occult blood test participation in Ontario.
    Honein-AbouHaidar GN; Rabeneck L; Paszat LF; Sutradhar R; Tinmouth J; Baxter NN
    BMC Cancer; 2014 Jul; 14():537. PubMed ID: 25062552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.